Tubulis GmbH. (12/3/24). "Press Release: Gilead and Tubulis Enter into Exclusive Option and Licence Agreement to Develop ADC Candidate for Select Solid Tumor Target". Foster City, CA & Munich. |
2024-12-03 |
Eckert & Ziegler SE. (12/3/24). "Press Release: Eckert & Ziegler – Changes in the Executive Board and Supervisory Board". Berlin. |
2024-12-03 |
Orbit Discovery Ltd.. (12/3/24). "Press Release: Orbit Discovery and Evergreen Theragnostics Expand Research Collaboration to Advance Targeted Therapeutics Development". Oxford & Springfield, NJ. |
2024-12-03 |
Nouscom S.r.l.. (12/3/24). "Press Release: Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer". Basel. |
2024-12-03 |
Eppendorf SE. (12/2/24). "Press Release: Eppendorf SE and DataHow AG Announce Strategic Collaboration to Advance Bioprocess Data Management". Hamburg & Jülich. |
2024-12-02 |
PTC Therapeutics, Inc.. (12/2/24). "Press Release: PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program". Warren, NJ. |
2024-12-02 |
Evotec SE. (11/29/24). "Press Release: Evotec Announces Change in Management Board. Dr Craig Johnstone Steps Down as Chief Operating Officer Effective 31 December 2024". Hamburg. |
2024-11-29 |
Mainz Biomed N.V.. (11/29/24). "Press Release: Mainz Biomed Announces Stock Split". Berkeley, CA & Mainz. |
2024-11-29 |
H. Lundbeck A/S. (11/18/24). "Press Release: Lundbeck Announces Expiration of Longboard Tender Offer and That All Tender Offer Conditions Are Fulfilled". |
2024-11-28 |
Idorsia Ltd.. (11/27/24). "Press Release: Idorsia Enters into Exclusive Negotiations for Global Rights to Aprocitentan". Allschwil. |
2024-11-27 |
Bio Inx B.V.. (11/27/24). "Press Release: Bio Inx and Carl Roth Partner to Expand Access to 3D Bioprinting Solutions". Ghent. |
2024-11-27 |
Kyan Health AG. (11/26/24). "Press Release: Kyan Health Raises $16.7m to Upgrade Workplace Wellness with AI-powered Preventative Care". |
2024-11-26 |
Acadia Pharmaceuticals Inc.. (11/26/24). "Press Release: Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711". San Diego, CA. |
2024-11-26 |
Saniona AB. (11/26/24). "Press Release: Saniona Announces Licensing Agreement with Acadia Pharmaceuticals for SAN711 in Neurological Diseases". |
2024-11-26 |
Medigene AG. (11/26/24). "Press Release: Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment". Basel. |
2024-11-26 |
Roche. (11/26/24). "Press Release: Roche Enters into a Definitive Agreement to Acquire Poseida Therapeutics, Including Cell Therapy Candidates and Related Platform technologies". Basel. |
2024-11-26 |
Cradle Bio B.V.. (11/26/24). "Press Release: Cradle Raises $73m Series B Led by IVP to Accelerate Adoption of AI-powered Protein Engineering". Amsterdam & Zurich. |
2024-11-26 |
Metrion Biosciences Ltd.. (11/25/24). "Press Release: Metrion Biosciences Appoints Lee Patterson as CEO". Cambridge. |
2024-11-25 |
Adragos Pharma GmbH. (11/25/24). "Press Release: Adragos Pharma Acquires Baccinex – a Leading Swiss Sterile Fill-Finish Expert". Munich & Courroux. |
2024-11-25 |
Agilent Technologies Inc.. (11/25/24). "Press Release: Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results". Santa Clara, CA. |
2024-11-25 |
Agilent Technologies Inc.. (11/25/24). "Press Release: Agilent Announces New Organizational Structure to Support its Market-Focused Strategy". Santa Clara, CA. |
2024-11-25 |
Bico Group AB. (11/25/24). "Press Release: Cellink Announces Further Right-sizing and Launches Sharpened Commercial Agenda". |
2024-11-25 |
Adcendo ApS. (11/25/24). "Press Release: Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline". Copenhagen. |
2024-11-25 |
Halozyme Therapeutics, Inc.. (11/22/24). "Press Release: Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions". San Diego, CA. |
2024-11-22 |
Novartis AG. (11/21/24). "Press Release: Addressing Unmet Needs for Inherited Neuromuscular Diseases. Novartis Has Acquired Kate Therapeutics to Further Enhance and Strengthen Our Ongoing Efforts to Advance Gene Therapies for Patients". |
2024-11-21 |
Versant Ventures. (11/21/24). "Press Release: Versant Ventures Unveils Pep2Tango Therapeutics Inc.". Potomac, MD. |
2024-11-21 |
Enveda. (11/21/24). "Press Release: Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates". Boulder, CO. |
2024-11-21 |
Bico Group AB. (11/21/24). "Press Release: Bico Has Entered into an Agreement to Divest Nanoscribe". |
2024-11-21 |
Revvity, Inc.. (11/20/24). "Press Release: Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK". Waltham, MA. |
2024-11-20 |
Infrareal Holding GmbH & Co. KG. (11/20/24). "Press Release: Infrareal Takes Over Pharmaceutical and Biotech Site in Orth, Lower Austria". Gütersloh. |
2024-11-20 |
Tagomics Ltd.. (11/20/24). "Press Release: Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent". Cambridge. |
2024-11-20 |
Glox Therapeutics Ltd.. (11/20/24). "Press Release: Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens". Glasgow. |
2024-11-20 |
Halozyme Therapeutics, Inc.. (11/18/24). "Press Release: Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec". San Diego, CA. |
2024-11-18 |
Mabel AI AB. (11/18/24). "Press Release: Partnership with Tolkförmedling Väst, the Largest Swedish Public Interpretation Agency, to Offer AI-based Interpretation in West Sweden". |
2024-11-18 |
CRISPR Therapeutics AG. (11/14/24). "Press Release: CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference". Zug & Boston, MA. |
2024-11-14 |
Halozyme Therapeutics, Inc.. (11/14/24). "Press Release: Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction". San Diego, CA. |
2024-11-14 |
Andera Partners. (11/13/24). "Press Release: Andera Partners Continues Its International Expansion and Announces the Opening of a Madrid Office". Paris & Madrid. |
2024-11-13 |
[iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz. |
2024-11-13 |
Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock. |
2024-11-13 |
Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel. |
2024-11-12 |
High-Tech Gründerfonds Management GmbH. (11/12/24). "Press Release: Zymofix Secures €2 Million to Scale Microbial Solutions for Sustainable Agriculture and Beyond". Ghent. |
2024-11-12 |
Mainz Biomed N.V.. (11/12/24). "Press Release: Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets". Berkeley, CA & Mainz. |
2024-11-12 |
Mediaire GmbH. (11/12/24). "Press Release: Mediaire Transforms Radiology with AI, Securing a European €12 Million Investment to Fuel Global Growth". |
2024-11-12 |
VarmX B.V.. (11/12/24). "Press Release: VarmX Announces Appointment of John Glasspool as CEO". Leiden. |
2024-11-12 |
Vilnius University. (11/11/24). "Press Release: Vilnius University Researchers Uncover New Gene Silencing Mechanism". |
2024-11-11 |
Bertelsmann Investments. (11/7/24). "Press Release: Bertelsmann Investments Makes Further Investments in Fast-growing Digital Health Market". Gütersloh. |
2024-11-07 |
Biocat. (11/7/24). "Press Release: Barcelona to Host BioSpain in 2025 and 2027". Madrid & Barcelona. |
2024-11-07 |
CRISPR Therapeutics AG. (11/7/24). "Press Release: CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference". Zug & Boston, MA. |
2024-11-07 |
BioSpring GmbH. (11/5/24). "Press Release: BioSpring Has Been Granted Manufacturing Authorization (ICH Q7) for cGMP-grade mRNA Production from the German Authorities". Frankfurt a. M.. |
2024-11-05 |
Rock Capital Group. (11/5/24). "Press Release: Praimera Biotech AG Rents 600 m² of Lab Office Space at Skygate in Hallbergmoos near Munich". Munich-Hallbergmoos. |
2024-11-05 |
PrognomiQ. (11/5/24). "Press Release: PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform". San Mateo, CA. |
2024-11-05 |
CRISPR Therapeutics AG. (11/5/24). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results". Zug & Boston, MA. |
2024-11-05 |
High-Tech Gründerfonds Management GmbH. (10/31/24). "Press Release: Berlin-Based Neurotech Startup Nuuron Secures Investment for the Development of a Digital Drug to Treat Alzheimer’s Disease". |
2024-10-31 |
TME Pharma N.V.. (10/31/24). "Press Release: TME Pharma Awarded €2.4 Million German Federal Grant to Support NOX-A12 Phase 2 Trial in Brain Cancer". Berlin. |
2024-10-31 |
Valanx Biotech GmbH. (10/29/24). "Press Release: Valanx Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development". Klosterneuburg & Rockville, MD. |
2024-10-29 |
Aignostics GmbH. (10/29/24). "Press Release: Aignostics Secures $34M Series B to Enhance Precision Medicine with AI". Berlin & New York, NY. |
2024-10-29 |
Biotest AG. (10/29/24). "Press Release: Biotest and SteinCares Partner to Improve Access to Plasma-derived Products in Latin America". Dreieich. |
2024-10-29 |
Inbrain Neuroelectronics S.L.. (10/29/24). "Press Release: Inbrain Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology". Barcelona. |
2024-10-29 |
Kynos Therapeutics Ltd.. (10/29/24). "Press Release: Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio". Freiburg. |
2024-10-29 |
Ryvu Therapeutics S.A.. (10/29/24). "Press Release: Ryvu Therapeutics to Collaborate with nCage Therapeutics on the Development of a Next-Generation ADC Platform". Krakow. |
2024-10-29 |
Ottimo Pharma Ltd.. (10/28/24). "Press Release: Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 20 |
2024-10-28 |
Kivu Bioscience. (10/28/24). "Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates". San Francisco, CA. |
2024-10-28 |
Ion Opticks Pty Ltd.. (10/25/24). "Press Release: Sciex and IonOpticks Announce Co-Marketing Agreement Between Aurora Series XS Range and the ZenoTOF Line". Melbourne. |
2024-10-25 |
AbbVie Inc.. (10/24/24). "Press Release: AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions". North Chicago, IL & Budapest. |
2024-10-24 |
Rentschler Biopharma SE. (10/24/24). "Press Release: Rentschler Biopharma Announces Largest Single Investment at Its Headquarters in Germany". Laupheim. |
2024-10-24 |
ICR Inc.. (10/22/24). "Press Release: ICR Healthcare Launches as a Unified Global Brand in Healthcare Strategic Communications and Investor Relations". New York, NY & London. |
2024-10-22 |
|transkript [Kääb, Georg]. (10/21/24). "Miltenyi Biotec: An Exclusive, Rare Interview with Founder Stefan Miltenyi. Interview by |transkript.de/Georg Kääb". |
2024-10-21 |
UpNano GmbH. (10/17/24). "Press Release: Industry Groups Invest in High Performance 2PP 3D Print Technology". Vienna. |
2024-10-17 |
BenevolentAI Ltd.. (10/17/24). "Press Release: BenevolentAI Appoints Kenneth Mulvany as Executive Chairman". London. |
2024-10-17 |
Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing
> Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA. |
2024-10-16 |
Antiverse Ltd.. (10/15/24). "Press Release: Antiverse Raises £3.5M ($4.6M) to Advance Generative AI Antibody Design Platform". Cardiff. |
2024-10-15 |
Forbion Capital Partners. (10/15/24). "Press Release: Forbion Raises in Excess of €2 Billion for Two New Funds". Naarden. |
2024-10-15 |
Shift Bioscience Ltd.. (10/15/24). "Press Release: Shift Bioscience Raises $16M to Advance Cell Simulation AI Platform". Cambridge. |
2024-10-15 |
Invios GmbH. (10/15/24). "Press Release: Invios Raises €8.2 Million in a Series A to Finance Pipeline Progress in Immuno-oncology". Vienna. |
2024-10-15 |
Innate Pharma S.A.. (10/14/24). "Press Release: Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board". |
2024-10-14 |
H. Lundbeck A/S. (10/14/24). "Press Release: Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline". Valby & La Jolla, CA. |
2024-10-14 |
Cosmo Pharmaceuticals N.V.. (10/11/24). "Press Release: Cosmo Pharmaceuticals Appoints New Chief Financial Officer". Dublin. |
2024-10-11 |
Lumicks Technologies B.V.. (10/10/24). "Press Release: Dutch Life Science Tools [Company] Lumicks Secures €20 Million from European Investment Bank to Accelerate Drug Discovery for Cancer". |
2024-10-10 |
Camp4 Therapeutics Corporation. (10/10/24). "Press Release: Camp4 Announces Pricing of Initial Public Offering". Cambridge, MA. |
2024-10-10 |
Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Proposed $150 Million Public Offering". Houston, TX & Tübingen. |
2024-10-10 |
Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Updated Phase 1b Clinical Data on ACTengine IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial". Houston, TX & Tübingen. |
2024-10-10 |
Booster Therapeutics GmbH. (10/10/24). "Press Release: Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases". Berlin. |
2024-10-10 |
Clock Bio Ltd.. (10/9/24). "Press Release: clock.bio Raises $5.3M Seed Funding and Decodes Genetic Atlas of Human Rejuvenation Factors". Cambridge. |
2024-10-09 |
Purespring Therapeutics Ltd.. (10/9/24). "Press Release: Purespring Therapeutics Raises £80/$105 Million in a Series B Financing to Transform the Treatment of Kidney Diseases". London. |
2024-10-09 |
a:head bio AG. (10/9/24). "Press Release: a:head Secures Pre-Series A Funding and Appoints Margarete Schramboeck and Madeline Lancaster to the Supervisory Board". Vienna. |
2024-10-09 |
Boehringer Ingelheim. (10/9/24). "Press Release: Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment". Ingelheim & South San Francisco, CA. |
2024-10-09 |
SphingoTec GmbH. (10/9/24). "Press Release: Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care". Hennigsdorf. |
2024-10-09 |
Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA. |
2024-10-09 |
Yumab GmbH. (10/8/24). "Press Release: Yumab and Molcure Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets". |
2024-10-08 |
Somagenetix AG. (10/8/24). "Press Release: Somagenetix AG Secures CHF 10 Million in Series A Financing to Advance Lentiviral Gene Therapy for Chronic Granulomatous Disease (CGD)". Zurich. |
2024-10-08 |
Lymphatica Medtech S.A.. (10/8/24). "Press Release: Lymphatica Medtech Closes €17.9m Series B Funding Round to Drive Innovation in Lymphedema Treatment". Lausanne. |
2024-10-08 |
Eversana. (10/7/24). "Press Release: Eversana Expands Global Commercialisation Operations With Berlin, Germany Office". Berlin. |
2024-10-07 |
Mérieux NutriSciences Corporation. (10/7/24). "Press Release: Mérieux NutriSciences Enters Agreement to Acquire Worldwide Food Testing Business of Bureau Veritas". Chicago, IL. |
2024-10-07 |
CrestOptics S.p.A.. (10/7/24). "Press Release: CrestOptics and Leica Microsystems Announce Strategic Collaboration to Expand Capabilities of Spinning Disk Microscopy". Rome. |
2024-10-07 |
Ten23 Health AG. (10/7/24). "Press Release: BD and Ten23 Health Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-enabled Prefillable Syringes". Franklin Lakes, NJ & Basel. |
2024-10-07 |
Enara Bio Ltd.. (10/3/24). "Press Release: Enara Bio Raises $32.5 Million Series B Financing to Advance First-in-Class Pipeline of TCR-based Immunotherapies Targeting Novel Dark Antigens". Oxford. |
2024-10-03 |
Kurma Partners. (10/3/24). "Press Release: Kurma Partners Achieves First Close of New EUR 250 Million Biofund IV". Paris. |
2024-10-03 |
Ferring Pharmaceuticals S.A.. (10/3/24). "Press Release: Ferring Bolsters Global Gene Therapy Supply Chain with European Manufacturing Facility". Saint-Prex. |
2024-10-03 |
LoQus23 Therapeutics Ltd.. (10/2/24). "Press Release: LoQus23 Therapeutics Announces £35 Million (c.$43 Million) Series A Financing to Advance Its Small Molecule Somatic Expansion Inhibition Therapy for Huntington’s Disease". Cambridge. |
2024-10-02 |